Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis. - Cook LM; Frieling JS; Nerlakanti N; McGuire JJ; Stewart PA; Burger KL; Cleveland JL; Lynch CC (Oncogene, 2019)